Skip to main content
ScholarsBetaWeill Cornell Medicine

Overview

Lisa D. Ravdin, PhD, ABPP-CN is a Board Certified Neuropsychologist and Director of the Weill Cornell Neuropsychology Service in the Department of Neurology & Neuroscience at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. After graduating from the Chicago Medical School doctoral program, she completed an internship at the West Haven VA Medical Center and Yale Epilepsy Program where she received the Jacob Levin Intern Award for Outstanding Clinical Scholarship. Subsequently, she underwent advanced training in a Neuropsycholgy Post Doctoral Fellowship at New York University School of Medicine-Hospital for Joint Diseases, as well as Neuropsychology Fellowship at the New York Hospital-Cornell Medical Center. Presently, her primary clinical and research activities focus on cognitive changes associated with neurologic disorders, and in particular, age-related diseases.  Dr. Ravdin is a member of the Weill Cornell Memory Disorders Program. In addition, she is a co-investigator on a number of research initiatives relating to cognitive decline associated with neurologic disease (Normal Pressure Hydrocephalus, Alzheimer's disease, Parkinson's disease) and depression.

Publications

59 publications

Funding

16 grantsView NIH portfolio on RePORTER ↗

Active

10 grants
  • Co-I
    Enhance II
    Administration for Community Living · 2024–2029
    90REGE0028-01-00
  • Co-I
    Quantitative MRI-based cerebral oxygen metabolism in Alzheimer's disease
    National Institute on Aging · 2023–2028
    R01AG080011-04
  • MPI
    PATH-Pain: A Primary Care-Based Psychosocial Intervention To Improve Cognitive and Depression Outcomes in Older Adults with MCI and Early Stage AD
    National Institute on Aging · 2021–2027
    R01AG070055-05
  • Co-I
    A Social Engaging Restorative Virtual Environment (SERVE) Volunteer Intervention to Support Social Engagement and Well-Being in Older Adults with Cognitive Impairment
    National Institute on Aging · 2023–2027 · via Cornell University - Ithaca
    R01AG082831-01
  • Co-I
    Center for Research and Education on Aging and Technology Enhancement - CREATE
    National Institute on Aging · 2022–2027
    P01AG073090-01A1
  • Co-I
    The effects of iron on oxidative stress and Alzheimer's biomarkers in amyloid-positive and negative elderly normal
    National Institute on Aging · 2020–2027
    R01AG068398-05
  • Co-I
    PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
    National Institute on Aging · 2022–2027 · via University of Arizona
    R01AG075122-01
  • Co-I
    Perimenopause in Brain Aging and Alzheimer's disease
    National Institute on Aging · 2021–2026 · via University of Arizona
    P01AG026572-17
  • Co-I
    The LUCINDA Trial
    National Institute on Aging · 2019–2026
    R01AG057681-02
  • Co-I
    The Center for Enhancing Neurocognitive Health, Abilities, Networks, & Community Engagement (ENHANCE).
    Administration for Community Living · 2019–2026
    90REGE0012-03-00
Completed grants (6)
  • Co-I
    A communication-based intervention for early stage dementia patient-caregiver dyads to increase engagement in advance care planning and reduce caregiver burden
    National Institute on Aging · 2021–2025
    R21AG070501-01A1
  • MPI
    Problem Adaptation Therapy for Mild Cognitive Impairment With Depression
    National Institute on Aging · 2016–2024
    R01AG050514-05
  • KP
    Cornell Roybal Center Translational Research Institute on Pain in Later Life-II
    National Institute on Aging · 2014–2019
    P30AG022845-11
  • Co-I
    A Personalized Self-Management Program for Older Adults With Chronic Pain and Negative Emotions
    Pfizer Inc. · 2017–2019
    28540451 YR 2
  • KP
    Home-Delivered Intervention for Depressed, Cognitively Impaired Elders
    National Institute of Mental Health · 2011–2017
    R01MH091045-05
  • KP
    Neuroimaging and Metabolomics Correlates of Cognitive Decline in Parkinson's Disease
    National Institute of Neurological Disorders and Stroke · 2009–2015
    R01NS064038-05